Researchers at the University of Rochester Medical Center today announced that they have launched a study to determine whether an experimental drug, rimonabant, can slow atherosclerosis, the fatty build-up in arteries that creates heart attack risk. In recent studies, rimonabant has been shown to decrease body weight, improve abnormal levels of blood sugars and fats (cholesterol) and to help willing patients quit smoking. Now researchers hope to add coronary artery disease (CAD), atherosclerosis within the arteries of the heart, to the list of maladies addressed. A decision on whether rimonabant is safe and effective and if so, for which uses, is expected from the U.S. Food and Drug Administration in 2006.
Unlike previous cholesterol drugs that treat some aspect of blood or blood vessel walls, rimonabant is a cannabinoid receptor antagonist, which exerts its effect in parts of the brain that control appetite and addictive behaviors. Results of previous studies show that rimonabant reduces triglycerides and increases HDL-C, or "good" cholesterol, independent of weight loss. The new study, titled STADIVARIUS (Strategy to Reduce Atherosclerosis Development Involving Administration of Rimonabant- The Intravascular Ultrasound Study), will explore whether these effects will impact the progression of atherosclerosis.
"Obesity, diabetes, high cholesterol and coronary artery disease have all reached epidemic proportions to become leading causes of death despite being largely preventable," said Frederick S. Ling, M.D., director of the Cardiac Catheterization Laboratory, associate professor of Medicine at the medical center and principal investigator for STRADIVARIUS. "These risk factors, called metabolic syndrome when combined in one person, feed off each other and are made much worse by smoking. New approaches are urgently needed, and our lab has the tools to measure accurately whether new treatments actually slow the progression of coronary artery diseasPage: 1 2 Related medicine news :1
Contact: Greg Williams
University of Rochester Medical Center
. Researchers suggest TB screening for all international adoptees2
. Researchers find vitamin B1 deficiency key to vascular problems for diabetic patients3
. Researchers link metal ions to neurodegenerative disease4
. Researchers develop criteria to detect bone mass deficiencies in children with chronic diseases5
. Researchers call for investigation into links between khat use and psychiatric disorders6
. Researchers use MRI to predict recovery after spinal cord injury7
. Researchers find deadly prescription drug effects 6 years before FDA8
. Researchers investigate impact of lifestyle on GI health9
. Researchers begin randomized double-blind trial of airway bypass treatment for emphysema10
. Researchers discover how antibiotic inhibits bacterial growth11
. Researchers urge caution in using ESAs for cancer-related anemia